On Monday, Praxair, Inc. (NYSE:PX)’s shares declined -1.01% to $111.84.
Praxair, Inc. (PX) declared it will build a new air separation unit (ASU) supporting its Detroit, Michigan, area pipeline system to meet the growing demand for industrial gases from customers in the region in addition to rare gas customers worldwide. This expansion coincides with renewals of multiple existing pipeline customer agreements. The project will comprise the installation of state-of-the-art operating equipment and systems.
The new 1,650 tons per day plant will start operations in 2017 and will supply existing pipeline customers with improved efficiency and continued reliability. The plant will also produce liquid oxygen, nitrogen, argon and rare gases for use by hospitals, food processors, and industrial companies supplying the automobile industry.
Praxair, Inc. produces, sells, and distributes atmospheric, process, and specialty gases, in addition to surface coatings in North America, Europe, South America, and Asia. The company offers atmospheric gases, such as oxygen, nitrogen, argon, and rare gases; and process gases comprising carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Cempra Inc (NASDAQ:CEMP)’s shares dropped -3.82% to $43.53.
Cempra, Inc. (CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, recently declared the completion of enrollment for the global Solitaire-IV Phase 3 trial of solithromycin in adult patients with moderate to moderately severe community-attained bacterial pneumonia (CABP). Top-line efficacy and safety data from this study are predictable to be declared by the end of the year.
Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attained bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.
At the end of Monday’s trade, Dicks Sporting Goods Inc (NYSE:DKS)‘s shares dipped -1.26% to $49.24.
DICK’S Sporting Goods (DKS), the largest U.S.-based, full-line omni-channel sporting goods retailer, will be opening its first All-American Sports Center on Thursday, July 23rd at McGowin Park in Mobile, Alabama (1390 Tingle Circle West).
The All-American Sports Center features a DICK’S Sporting Goods and a Field & Stream store in one location under the same roof. Customers benefit from an expanded assortment and the ability to move between the two stores once inside, creating a unique, exciting shopping experience.
Dick’s Sporting Goods, Inc. operates as a sporting goods retailer primarily in the eastern United States. The company provides hardlines, counting sporting goods equipment, fitness equipment, golf equipment, and hunting and fishing gear products; apparel; and footwear products and accessories.
Hospira, Inc. (NYSE:HSP), ended its Monday’s trading session with 0.11% gain, and closed at $89.35.
Hospira, Inc. (HSP), the world’s leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, will release its second-quarter 2015 results on Wednesday, July 29, 2015, before the U.S. stock market open. Given the company’s pending merger with Pfizer Inc., Hospira will not be holding a conference call.
Hospira, Inc. provides injectable drugs and infusion technologies to develop, manufacture, distribute, and market products worldwide. The company operates through Americas, EMEA, and APAC segments. It provides specialty injectable pharmaceuticals, which comprise about 200 injectable generic drugs in multiple dosages and formulations; and proprietary specialty injectables, such as Precedex, a proprietary drug for sedation.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
